nfr-logonfr-logo
PROSJEKTBANKEN
Switch to English
Se statistikken
Se prosjektene

0 antall prosjekter

Dato fra ny til gammel

H20-ERC-European Research Council

Coincidence detection of proteins and lipids in regulation of cellular membrane dynamics

Coincidence detection of proteins and lipids in regulation of cellular membrane dynamics

Tildelt: kr 23,3 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

Tildelt: kr 1,0 mill.

Prosjektperiode: 2019-2024

Sted: Rogaland og 2 andre

H20-CROSST-Cross-theme

System for AcceleroMeter-Based Assessment of cardiac FUNction

In patients undergoing open-heart surgeries, perioperative cardiac monitoring is used to track the functioning of the heart and identify complications. However, myocardial failure and other severe complications can escape detection using current monitoring technologies, given the trade-offs betwe...

Tildelt: kr 15,0 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Advanced Secure Cloud Encrypted Platform for Internationally Orchestrated Solutions in Healthcare

Advanced Secure Cloud Encrypted Platform for Internationally Orchestrated Solutions in Healthcare

Tildelt: kr 6,3 mill.

Prosjektperiode: 2018-2022

Sted: Troms - Romsa - Tromssa

H20-ERC-European Research Council

Set to change: early life factors restricting and promoting neurocognitive plasticity through life

Set to change: early life factors restricting and promoting neurocognitive plasticity through life

Tildelt: kr 18,7 mill.

Prosjektperiode: 2018-2023

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

MAnufacturing of TUmour-REactive Natural Killer cells

This project will provide future-oriented translational research training designed to bridge the gap between basic research and applied development of new cell-based therapeutic products by the biotech industry and their clinical use for incurable diseases. This will be done on the example of act...

Tildelt: kr 2,7 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

conect4children (COllaborative Network for European Clinical Trials For Children)

Paediatric medicines development is embedded in the European policy, legislation and in the work of the pharmaceutical industry but currently the potential of this effort is not realised. The conect4children (c4c) project will address the critical problems with the design, implementation and ope...

Tildelt: kr 6,5 mill.

Prosjektperiode: 2018-2024

Sted: Vestland

H20-INFRA-Research infrastructures

EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts

Counteracting high attrition rates in oncology drug development and providing optimal therapeutic management of cancer patients require preclinical models that properly recapitulate the complexity and diversity of human tumours. Patient-derived tumour xenografts (PDXs), established by transplanti...

Tildelt: kr 0,90 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Personalised maxillofacial bone regeneration

Personalised maxillofacial bone regeneration

Tildelt: kr 9,1 mill.

Prosjektperiode: 2018-2021

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial

Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial

Tildelt: kr 2,4 mill.

Prosjektperiode: 2018-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative

Bipolar disorder (BD) is a prevalent mental disorder and a leading cause of suicide. Lithium (Li) is the key mood stabilizer for prevention of BD relapse and suicide. Whilst many cases become asymptomatic with Li treatment, the majority show sub-optimal response. Identifying biomarkers for predic...

Tildelt: kr 1,7 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock

Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock

Tildelt: kr 2,8 mill.

Prosjektperiode: 2018-2022

Sted: Troms - Romsa - Tromssa

H20-ERC-European Research Council

Imaging Perfusion Restrictions from Extracellular Solid Stress

Even the perfect cancer drug must reach its target to have an effect. The ImPRESS project main objective is to develop a novel imaging paradigm coined Restricted Perfusion Imaging (RPI) to reveal - for the first time in humans - vascular restrictions in solid cancers caused by mechanical solid st...

Tildelt: kr 14,0 mill.

Prosjektperiode: 2018-2023

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

A European Training Network for Functional Hybrid Coatings by Molecular Layer Deposition

A European Training Network for Functional Hybrid Coatings by Molecular Layer Deposition

Tildelt: kr 5,3 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model

How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model

Tildelt: kr 1,2 mill.

Prosjektperiode: 2018-2022

Sted: Innlandet

H20-HEALTH-Health, demographic change and wellbeing

Empathic, Expressive, Advanced Virtual Coach to Improve Independent Healthy-Life-Years of the Elderly

The EMPATHIC Research & Innovation project will research, innovate, explore and validate new paradigms and platforms, laying the foundation for future generations of Personalised Virtual Coaches to assist elderly people living independently at and around their home. Innovative multimodal face an...

Tildelt: kr 4,1 mill.

Prosjektperiode: 2017-2021

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Personalised In-Silico Cardiology

Improving healthcare systems mandates a shift towards personalised and preventive management of disease. Specifically, the management of cardiovascular diseases has a huge impact on European society in terms of mortality, morbidity and healthcare costs, being responsible for 1.9 million deaths in...

Tildelt: kr 8,0 mill.

Prosjektperiode: 2017-2022

Sted: Vestfold og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

International impact of TALK©: a simple and practical approach to multi-professional structured feedback and debriefing, to be used after unplanned learning events in clinical environments.

International impact of TALK©: a simple and practical approach to multi-professional structured feedback and debriefing, to be used after unplanned learning events in clinical environments.

Tildelt: kr 0,50 mill.

Prosjektperiode: 2017-2022

Sted: Rogaland

H20-MSCA-Marie Sklodowska-Curie actions

Supporting Pioneer doctoral Researchers through 3i Knowledge partnerships

The SPaRK Programme is driven by the need to develop future leaders whose skills combine disciplinary excellence with a capacity for interdisciplinary and intersectoral working that creates genuinely disruptive thinkers. SPaRK recognises that genuinely game-changing intersectoral, international a...

Tildelt: Skjult

Prosjektperiode: 2017-2022

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

FrontierResearchCompentences@CNAP

FrontierResearchCompentences@CNAP

Tildelt: Skjult

Prosjektperiode: 2017-2022

Sted: Oslo

H20-INFRA-Research infrastructures

Paediatric Clinical Research Infrastructure Network

Paediatric Clinical Research Infrastructure Network

Tildelt: kr 0,45 mill.

Prosjektperiode: 2017-2021

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine

Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine

Tildelt: kr 5,1 mill.

Prosjektperiode: 2017-2021

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia

Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia

Tildelt: kr 2,7 mill.

Prosjektperiode: 2016-2021

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

High Performance Soft-tissue Navigation

High Performance Soft-tissue Navigation

Tildelt: kr 15,0 mill.

Prosjektperiode: 2016-2021

Sted: Oslo og 2 andre

H20-FET-Future and Emerging Technologies

A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours

A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours

Tildelt: kr 14,5 mill.

Prosjektperiode: 2016-2022

Sted: Oslo

H20-SECURITY-Secure societies - Protecting freedom and security of Europe and its citizens

EnhANcing emergencY management and response to extreme WeatHER and climate Events

The ultimate purpose of ANYWHERE is to empower exposed responder institutions and citizens to enhance their anticipation and pro-active capacity of response to face extreme and high-impact weather and climate events. This will be achieved through the operational implementation of cutting-edge inn...

Tildelt: kr 5,6 mill.

Prosjektperiode: 2016-2019

Sted: Trøndelag - Trööndelage og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

The basic concept of our proposal is to develop nanoparticle-based encapsulated libraries of different immunotherapeutic biomolecules for treatment after surgery as part of a novel cancer management strategy. The current state-of-art for the management of cancer starts with surgery, after identif...

Tildelt: kr 5,1 mill.

Prosjektperiode: 2016-2019

Sted: Vestland

H20-MSCA-Marie Sklodowska-Curie actions

Wireless In-Body Environment

WiBEC (Wireless In-Body Environment Communications) is an Innovative Training Network for 16 young researchers, who will be recruited and trained in coordinated manner by Academia, Industry, and Medical Centres. This training will address the Social, Health, and Technology challenges of the H2020...

Tildelt: kr 12,2 mill.

Prosjektperiode: 2016-2019

Sted: Oslo og 2 andre

H20-TWINING-Twinning of research institutions

Strategies towards Excellence in Immuno-Oncology

Strategies towards Excellence in Immuno-Oncology

Tildelt: kr 1,5 mill.

Prosjektperiode: 2016-2018

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Children’s Liver Tumour European Research Network

Liver cancer in the paediatric population is rare with an incidence approximately 1-1.5 per million population. The commonest tumour seen in the childhood population is hepatoblastoma (HB), usually seen in young children and infants. Much rarer (about 10% of paediatric liver cancers) is hepatocel...

Tildelt: kr 0,96 mill.

Prosjektperiode: 2016-2021

Sted: Oslo

12345